{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T23:10:13Z","timestamp":1756249813750,"version":"3.44.0"},"reference-count":41,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aktuelle Urol"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>\n   Epidemiologische Daten zeigen einen klaren Zusammenhang zwischen Alter, Prostatavergr\u00f6\u00dferung und den damit verbundenen Beschwerden. Das benigne Prostatasyndrom verl\u00e4uft im Regelfall chronisch progredient und ein erheblicher Teil der BPS-Patienten, die vor der Entscheidung \u201ekonservative vs. chirurgische Therapie\u201c stehen sind hochbetagt und leiden oft an zahlreichen Komorbidit\u00e4ten, sodass der Grundsatz des \u201enihil nocere\u201c besonders ernst zu nehmen ist. Die Nutzen-Risiko-Absch\u00e4tzung ist sowohl bei der medikament\u00f6sen als auch bei der chirurgischen Therapie mit gro\u00dfer Sorgfalt vorzunehmen. Nach Sichtung der Literatur inclusive der einschl\u00e4gigen Leitlinien kommt der Autor zu dem Schluss, dass es bei entsprechender Indikation kaum Gr\u00fcnde gibt, geriatrischen Patienten eine der zahlreichen interventionellen Optionen zu versagen, vielleicht mit der Ausnahme des tats\u00e4chlich bereits pflegebed\u00fcrftigen Patientenkollektivs.\n    <\/jats:p>","DOI":"10.1055\/a-2599-8213","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T20:04:12Z","timestamp":1749153852000},"page":"439-444","source":"Crossref","is-referenced-by-count":0,"title":["Benigne Prostatahyperplasie mit Blasenentleerungsst\u00f6rung beim geriatrischen Patienten: Aktive (medikament\u00f6se oder operative) Therapie vs. Katheterversorgung"],"prefix":"10.1055","volume":"56","author":[{"given":"Peter Jochen","family":"Olbert","sequence":"additional","affiliation":[{"name":"Urologie, Brixsana private clinic, Brixen, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00345-010-0638-z","article-title":"Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS\/BPH indicators in the German male community-dwelling population aged 50 years or older","volume":"29","author":"R Berges","year":"2011","journal-title":"World J Urol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1159\/000052527","article-title":"Male lower urinary tract symptoms and related health care seeking in Germany","volume":"39","author":"RR Berges","year":"2001","journal-title":"Eur Urol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/s0022-5347(17)49698-4","article-title":"The development of human benign prostatic hyperplasia with age","volume":"132","author":"SJ Berry","year":"1984","journal-title":"J Urol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/bju.12728","article-title":"Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis","volume":"115","author":"M Gacci","year":"2015","journal-title":"BJU Int"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3109\/13685538.2015.1062980","article-title":"Connections between lower urinary tract symptoms related to benign prostatic enlargement and metabolic syndrome with its components: a systematic review and meta-analysis","volume":"18","author":"GI Russo","year":"2015","journal-title":"Aging Male"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00345-015-1626-0","article-title":"Meta-analysis of metabolic syndrome and benign prostatic hyperplasia in Chinese patients","volume":"34","author":"C Zou","year":"2016","journal-title":"World J Urol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/s0090-4295(02)02371-3","article-title":"Benign prostatic hyperplasia: a progressive disease of aging men","volume":"61","author":"M Emberton","year":"2003","journal-title":"Urology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1056\/NEJM199802263380901","article-title":"The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group","volume":"338","author":"JD McConnell","year":"1998","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-5347(05)67962-1","article-title":"Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study","volume":"163","author":"CG Roehrborn","year":"2000","journal-title":"J Urol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/j.1464-410X.2008.07717.x","article-title":"Progression of benign prostatic hyperplasia: systematic review of the placebo arms of clinical trials","volume":"102","author":"M Emberton","year":"2008","journal-title":"BJU Int"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/nau.22222","article-title":"Can we identify men who will have complications from benign prostatic obstruction (BPO)? ICI-RS 2011","volume":"31","author":"M Oelke","year":"2012","journal-title":"Neurourol Urodyn"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s40266-013-0064-1","article-title":"Studies to reduce unnecessary medication use in frail older adults: a systematic review","volume":"30","author":"J Tjia","year":"2013","journal-title":"Drugs Aging"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1002\/nau.23554","article-title":"Alpha-1 adrenergic antagonists, 5-alpha reductase inhibitors, phosphodiesterase type 5 inhibitors, and phytotherapic compounds in men with lower urinary tract symptoms suggestive of benign prostatic obstruction: A systematic review and meta-analysis of urodynamic studies","volume":"37","author":"F Fusco","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.5173\/ceju.2021.132.R1","article-title":"The effect of pharmacotherapy on prostate volume, prostate perfusion and prostate-specific antigen (prostate morphometric parameters) in patients with lower urinary tract symptoms and benign prostatic obstruction. A systematic review and meta-analysis","volume":"74","author":"V Sakalis","year":"2021","journal-title":"Cent European J Urol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.eururo.2009.09.035","article-title":"The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study","volume":"57","author":"CG Roehrborn","year":"2010","journal-title":"Eur Urol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000019919","article-title":"A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction","volume":"36","author":"B Djavan","year":"1999","journal-title":"Eur Urol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"h5398","DOI":"10.1136\/bmj.h5398","article-title":"The risk of fall and fracture with the initiation of a prostate-selective alpha antagonist: a population based cohort study","volume":"351","author":"B Welk","year":"2015","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.12809\/hkmj209049","article-title":"Hong Kong Geriatrics Society and Hong Kong Urological Association consensus on personalised management of male lower urinary tract symptoms in the era of multiple co-morbidities and polypharmacy","volume":"27","author":"PSK Chu","year":"2021","journal-title":"Hong Kong Med J"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/j.1755-3768.2008.01442.x","article-title":"Intraoperative floppy iris syndrome (IFIS): a practical approach to medical and surgical considerations in cataract extractions","volume":"87","author":"A Storr-Paulsen","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/s0090-4295(98)00654-2","article-title":"Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group","volume":"53","author":"CG Roehrborn","year":"1999","journal-title":"Urology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/ageing\/afv077","article-title":"Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014)","volume":"44","author":"M Oelke","year":"2015","journal-title":"Age Ageing"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.juro.2016.11.082","article-title":"The Cardiovascular Safety of Dutasteride","volume":"197","author":"SC Skeldon","year":"2017","journal-title":"J Urol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/s0090-4295(01)00985-2","article-title":"Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia","volume":"57","author":"SA Kaplan","year":"2001","journal-title":"Urology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"l1204","DOI":"10.1136\/bmj.l1204","article-title":"Incidence of type 2 diabetes mellitus in men receiving steroid 5alpha-reductase inhibitors: population based cohort study","volume":"365","author":"L Wei","year":"2019","journal-title":"BMJ"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1046\/j.1464-410x.1996.11012.x","article-title":"Long-term predictive role of urodynamics: an 8-year follow-up of prostatic surgery for lower urinary tract symptoms","volume":"78","author":"KM Jensen","year":"1996","journal-title":"Br J Urol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172590","article-title":"Diagnostic value of urodynamic bladder outlet obstruction to select patients for transurethral surgery of the prostate: Systematic review and meta-analysis","volume":"12","author":"M Kim","year":"2017","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1007\/s00345-022-04179-w","article-title":"Transurethral resection of the prostate in 85+ patients: a retrospective, multicentre study","volume":"40","author":"M Lotterstatter","year":"2022","journal-title":"World J Urol"},{"key":"ref29","first-page":"50","article-title":"Is transurethral resection of the prostate safe and effective in the over 80-year-old?","volume":"83","author":"RD Brierly","year":"2001","journal-title":"Ann R Coll Surg Engl"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.purol.2017.02.005","article-title":"Morbi-mortality of transurethral resection of the prostate in patients aged 75 and over","volume":"27","author":"PL Evrard","year":"2017","journal-title":"Prog Urol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1080\/003655998750015430","article-title":"Outcome of transurethral prostatectomy in men over 80 years","volume":"32","author":"LB Ilkjaer","year":"1998","journal-title":"Scand J Urol Nephrol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/jgs.14665","article-title":"Functional Outcomes After Transurethral Resection of the Prostate in Nursing Home Residents","volume":"65","author":"AM Suskind","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.76384","article-title":"Holmium Laser Enucleation of the Prostate (HoLEP) Versus Transurethral Resection of the Prostate (TURP) in Elderly Patients: Insights Into Recovery, Complications, and Risk Factors","volume":"16","author":"N Bayraktar","year":"2024","journal-title":"Cureus"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.urology.2019.06.025","article-title":"Are Outcomes of Thulium Laser Enucleation of the Prostate Different in Men Aged 75 and Over? A Propensity Score Analysis","volume":"132","author":"D Castellani","year":"2019","journal-title":"Urology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jsxm.2016.03.372","article-title":"Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study","volume":"13","author":"KT McVary","year":"2016","journal-title":"J Sex Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.juro.2016.12.045","article-title":"Convective Thermal Therapy: Durable 2-Year Results of Randomized Controlled and Prospective Crossover Studies for Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia","volume":"197","author":"CG Roehrborn","year":"2017","journal-title":"J Urol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00345-022-04258-y","article-title":"Rezum water vapor therapy for the treatment of patients with urinary retention and permanent catheter dependence secondary to benign prostate hyperplasia: a systematic review of the literature","volume":"41","author":"T Spinos","year":"2023","journal-title":"World J Urol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012832.pub2","article-title":"Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia","volume":"5","author":"JH Jung","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"ref39","first-page":"8802","article-title":"Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study","volume":"24","author":"CG Roehrborn","year":"2017","journal-title":"Can J Urol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.urology.2020.12.022","article-title":"The iTind Temporarily Implanted Nitinol Device for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled Trial","volume":"153","author":"B Chughtai","year":"2021","journal-title":"Urology"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/JU.0000000000003568","article-title":"The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia","volume":"210","author":"SA Kaplan","year":"2023","journal-title":"J Urol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/CU9.0000000000000122","article-title":"Aquablation in men with benign prostate hyperplasia: A systematic review and meta-analysis","volume":"17","author":"DC Chen","year":"2023","journal-title":"Curr Urol"}],"container-title":["Aktuelle Urologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2599-8213.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T22:40:34Z","timestamp":1756248034000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2599-8213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":41,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2025,8,26]]},"published-print":{"date-parts":[[2025,9]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2599-8213","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0001-7868","1438-8820"],"issn-type":[{"type":"print","value":"0001-7868"},{"type":"electronic","value":"1438-8820"}],"subject":[],"published":{"date-parts":[[2025,6,5]]}}}